IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

AFLATOXINS 261
Kazemi-Shirazi, L., Peterman, D. & Müller, C. (2000) Hepatitis B virus DNA in sera and liver
tissue of HBsAg negative patients with chronic hepatitis C. J. Hepatol., 33, 785–790
Kensler, T.W., Egner, P.A., Davidson, N.E. Roebuck, B.D., Pikul, A. & Groopman, J.D. (1986)
Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic
tumorigenesis in rats fed ethoxyquin: Role of induction of glutathione S-transferases. Cancer
Res., 46, 3924–3931
Kensler, T.W., Egner, P.A., Dolan, P.M., Groopman, J.D. & Roebuck, B.D. (1987) Mechanism of
protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3thione
(oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res., 47,
4271–4277
Kensler, T.W., Gange, S.J., Egner, P.A., Dolan, P.M., Muñoz, A., Groopman, J.D., Rogers, A.E.
& Roebuck, B.D. (1997) Predictive value of molecular dosimetry: Individual versus group
effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer. Cancer Epidemiol.
Biomarkers Prev., 6, 603–610
Kensler, T.W., He, X., Otieno, M., Egner, P.A., Jacobson, L.P., Chen, B., Wang, J.-S., Zhu, Y.-R.,
Zhang, B.-C., Wang, J.-B., Wu, Y., Zhang, Q.-N., Qian, G.-S., Kuang, S.-Y., Fang, X., Li, Y.-
F., Yu, L.-Y., Prochaska, H.J., Davidson, N.E., Gordon, G.B., Gorman, M.B., Zarba, A.,
Enger, C., Muñoz, A., Helzlsouer, K.J. & Groopman, J.D. (1998) Oltipraz chemoprevention
trial in Qidong, People’s Republic of China: Modulation of serum aflatoxin albumin adduct
biomarkers. Cancer Epidemiol. Biomarkers Prev., 7, 127–134
Kensler, T.W., Groopman, J.D., Sutter, T.R., Curphey, T.J. & Roebuck, B.D. (1999) Development
of cancer chemopreventive agents: Oltipraz as a paradigm. Chem. Res. Toxicol., 12, 113–126
Kew, M.C., Yu, M.C., Kedda, M.A., Coppin, A., Sarkin, A. & Hodkinson, J. (1997) The relative
roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern
African blacks. Gastroenterology, 112, 184–187
Kihara, T., Matsuo, T., Sakamoto, M., Yasuda, Y., Yamamoto, Y. & Tanimura, T. (2000) Effects
of prenatal aflatoxin B 1 exposure on behaviors of rat offspring. Toxicol. Sci., 53, 392–399
Kim, E.K., Shon, D.H., Ryu, D., Park, J.W., Hwang, H.J. & Kim, Y.B. (2000) Occurrence of
aflatoxin M 1 in Korean dairy products determined by ELISA and HPLC. Food Addit.
Contam., 17, 59–64
Kirby, G.M., Wolf, C.R., Neal, G.E., Judah, D.J., Henderson, C.J., Srivatanakul, P. & Wild, C.P.
(1993) In vitro metabolism of aflatoxin B 1 by normal and tumorous liver tissue from
Thailand. Carcinogenesis, 14, 2613–2620
Kirby, G.M., Chemin, I., Montesano, R., Chisari, F.V., Lang, M.A. & Wild, C.P. (1994a) Induction
of specific cytochrome P450s involved in aflatoxin B 1 metabolism in hepatitis B virus
transgenic mice. Mol. Carcinog., 11, 74–80
Kirby, G.M., Pelkonen, P., Vatanasapt, V., Camus, A.-M., Wild, C.P. & Lang, M.A. (1994b) Association
of liver fluke (Opisthorchis viverrini) infestation with increased expression of cytochrome
P450 and carcinogen metabolism in male hamster liver. Mol. Carcinog., 11, 81–89
Kirby, G.M., Batist, G., Alpert, L., Lamoureux, E., Cameron, R.G., Alaoui-Jamali, M.A. (1996a)
Overexpression of cytochrome P-450 isoforms involved in aflatoxin B 1 bioactivation in
human liver with cirrhosis and hepatitis. Toxicol. Pathol., 24, 458–467
Kirby, G.M., Batist, G., Fotouhi-Ardakani, N., Nakazawa, H., Yamasaki, H., Kew, M., Cameron,
R.G. & Alaoui-Jamali, M.A. (1996b) Allele-specific PCR analysis of p53 codon 249 AGT
transversion in liver tissues from patients with viral hepatitis. Int. J. Cancer, 68, 21–25